By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CorMedix 

86 Summit Avenue
Suite 301
Summit  New Jersey  07901  U.S.A.
Phone: 908-517-9500 Fax: 908-522-9199


SEARCH JOBS








Company News
CorMedix (CRMD) Files Request With FDA For QIDP Designation For Neutrolin 12/4/2014 12:55:52 PM
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved In Germany 12/4/2014 11:10:20 AM
CorMedix (CRMD) To Announce Third Quarter 2014 Results On November 13, 2014; Conference Call Hosted At 9 Am On Friday, November 14, 2014 11/7/2014 8:05:18 AM
CorMedix (CRMD) Receives Approval From FDA To Initiate A Clinical Trial For Neutrolin In The U.S. 10/27/2014 10:21:12 AM
CorMedix (CRMD) Announces FDA IND Filing For Neutrolin┬« In United States 9/25/2014 8:27:01 AM
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union 9/22/2014 8:50:51 AM
CorMedix (CRMD) Amends And Restates Outstanding Securities To Remove Provisions Causing Derivative Liability Classification 9/16/2014 9:33:11 AM
FDA Accepts CorMedix (CRMD) Pivotal Phase 3 Study Protocol 8/15/2014 8:25:17 AM
CorMedix (CRMD) Granted Extension Of NYSE-MKT Listing 7/24/2014 11:05:55 AM
CorMedix (CRMD) Finalizes Pivotal Phase 3 Study Protocol For FDA 6/24/2014 6:31:58 AM
12345678
//-->